# Comprehensive care
for every skin type

At Galenicum Derma we believe that treating the skin means understanding the whole body. That is why we develop solutions co-developed with leading dermatologists, to the safety and quality standards of the pharmaceutical industry, and with a clear purpose: to empower the patient.

## Our DermoBiotics method

from skin condition to patent.

### We identify the skin condition

We scientifically verify that the skin condition is linked to an imbalance in the gut microbiota. We only develop dermobiotics where there is a solid foundation for action.

### We isolate strains

We select probiotic strains from different genera and species with demonstrated activity. Not all bacteria are equal: we look for those with the exact profile for each skin condition.

### We compare in vitro

We test candidate strains in the laboratory, measuring their effect on the inflammatory markers specific to each condition. Only those that demonstrate a real and differential effect move forward.

### Pilot study

We test the best strain combinations in people, comparing different probiotic blends to identify which produces the most significant clinical improvement.

### Patent

The winning blend is patented. Each strain is registered with a unique code that guarantees its traceability.

### Clinical Study

We validate efficacy with a randomised, double-blind, placebo-controlled clinical trial. The results are published in scientific journals. Because saying it works is not enough: it has to be proven.

History

## Galenicum Derma

Galenicum Derma is a division of the Galenicum Health pharmaceutical group, a Spanish laboratory headquartered in Barcelona, founded in 2003.

We know what it means to live with a skin condition and we are convinced that the best results are achieved by working closely with excellence in dermatology. That is why we are committed to co-development with expert, specialised dermatologists to design innovative solutions with superior efficacy, backed by scientific and clinical evidence.

We offer a 360º approach to the most common skin conditions, with a portfolio that includes topical and oral medicines, food supplements and dermocosmetics, which we develop and produce under the safety and quality standards of the pharmaceutical industry.

We believe in a conscious future and are committed to empowering patients so that, with our help, they can embrace life again.